Simpson Thacher represented the underwriters in the initial public offering and Regulation S offering by Fusen Pharmaceutical Company Limited (“Fusen Pharmaceutical”). Fusen Pharmaceutical offered an aggregate…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
